U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H21NO
Molecular Weight 291.3868
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTINOLINE

SMILES

OC(C#CCN1CCCC1)(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=LWPXJPFOEPMIRG-UHFFFAOYSA-N
InChI=1S/C20H21NO/c22-20(18-10-3-1-4-11-18,19-12-5-2-6-13-19)14-9-17-21-15-7-8-16-21/h1-6,10-13,22H,7-8,15-17H2

HIDE SMILES / InChI

Description

Butinoline (also known as azulone) was used as an antispasmodic drug to treat gastritis.

Approval Year

Unknown
149124
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Not Provided
511
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
[Cytological studies in evaluation of the therapeutic efficacy of an azulene-containing preparation (azulone liquidum) in gastritis].
1959-08-22
[Prophylaxis and therapy of radiodermatitis with azulone preparations].
1956
[Treatment of gastritis; clinical observations of the effect of azulone].
1952-01-04
Patents

Patents

US5843408
2

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
Butinoline [WHO-DD]
Preferred Name English
BUTINOLINE
INN   WHO-DD  
INN  
Official Name English
butinoline [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29704
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID3046295
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
FDA UNII
G216926E9T
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
ChEMBL
CHEMBL1442660
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
CAS
968-63-8
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
DRUG CENTRAL
448
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
WIKIPEDIA
BUTINOLINE
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
SMS_ID
100000088612
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
INN
1631
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
NCI_THESAURUS
C78064
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
EVMPD
SUB06020MIG
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
PUBCHEM
68943
Created by admin on Mon Mar 31 18:19:01 GMT 2025 , Edited by admin on Mon Mar 31 18:19:01 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of BUTINOLINE
SALT/SOLVATE (PARENT)
Structure of BUTINOLINE PHOSPHATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966